Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Serum lipid metabolite composition, kit and application

A kit and marker technology, applied in clinical medicine, medicine, and analytical chemistry, to achieve the effect of reducing lung cancer mortality, high sensitivity, and good application prospects

Active Publication Date: 2022-05-06
DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, few studies have identified suitable biomarkers for use in clinical trials for lung cancer diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum lipid metabolite composition, kit and application
  • Serum lipid metabolite composition, kit and application
  • Serum lipid metabolite composition, kit and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] 1. Collection of Serum Samples

[0025] Before sampling, all volunteers included in the study signed the informed consent. Fasting serum samples from 63 female healthy controls and 64 lung cancer patients (including non-smoking females with stage 0, stage I, stage II and stage III-IV lung cancer) were collected. All subjects fasted for more than 8 hours, and fasting blood was collected. After blood collection, the serum was separated and stored in a -80°C refrigerator.

[0026] 2. Analysis method

[0027] 2.1 Pretreatment of serum samples

[0028] Thaw the blood sample at 4°C, take 40 μL serum sample, add 300 μL methanol solution containing internal standard 6.7 μg / mL palmitic acid-16,16,16-d 3 and 3.3 μg / mL phosphatidylethanolamine PE15:0 / 15:0 , then rotate for 1 min, and then add 1 mL of methyl tert-butyl ether to fully extract the lipids. Then 300 μL of water was added for phase separation. The mixture was centrifuged at 10000g, 4°C for 10 minutes. The superna...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a new serum lipid metabolite combination and its use as a marker in the preparation of a non-smoking female lung cancer diagnostic kit. The combination of serum lipid metabolites includes: eicosadienoic acid FA C20:2, eicosatetraenoic acid FA C20:4, tetracosatetraenoic acid FA C24:4, phosphatidylcholine PC20: 1 / 22:6, phosphatidylinositol PI18:0 / 20:5 and phosphatidylethanolamine PE18:0p / 22:4. The combination of serum lipid metabolites can be used for auxiliary diagnosis of lung cancer in non-smoking women, and has the characteristics of low detection cost, good repeatability, high sensitivity and specificity. At the same time, the combination of lipid metabolites also has a good effect on the diagnosis of early lung cancer in non-smoking women.

Description

technical field [0001] The invention relates to the application of a new serum combined marker in the diagnosis of lung cancer in non-smoking women. It belongs to the field of analytical chemistry, clinical medicine and medicine. Background technique [0002] Lung cancer is one of the malignant tumors with high morbidity and mortality in the world (Document 1: Yu et al., Globallipidomics reveals two plasma lipids as novel biomarkers for the detection of squamous cell lung cancer: A pilot study, oncol.lett.16 (2018) 761-768.). In recent years, the incidence of lung cancer in women has increased, even though most women do not smoke. Lung cancer is a heterogeneous disease with multiple subtypes with distinct histological and molecular biological features. In addition, female lung cancer appears to differ from males in terms of environmental risk factors and histologic type. Lung cancer among non-smokers has obvious gender bias, women are more likely to suffer from non-smoki...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574
CPCG01N33/57488G01N33/57423
Inventor 许国旺哈马达努尔刘心昱
Owner DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com